Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin

Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin

Abstract Onchocerciasis is a parasitic disease transmitted by black flies. Human onchocerciasis is a public health and socioeconomic problem in Nigeria. Its prevalence and morbidity have reduced over the years because of control efforts especially, Mass Drug Administration with ivermectin. The curre...

Full description

Bibliographic Details
Main Authors:	Friday Maduka Chikezie, Kenneth Nnamdi Opara, Peace Mayen Edwin Ubulom, Clement Ameh Yaro, Rasha Khalifah Al-Akeel, Mike Yaw Osei-Atweneboana, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-04-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-31446-6

Similar Items

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Repellency and insecticidal properties of seed oil of Jatropha curcas L. against American cockroach, Periplaneta americana L.
by: Peace Mayen Edwin Ubulom, et al.
Published: (2021-01-01)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Pyrethroid insecticides susceptibility profiles and evaluation of L1014F kdr mutant alleles in Culex quinquefasciatus from lymphatic filariasis endemic communities
by: Martina Anurika Okafor, et al.
Published: (2023-10-01)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002-01-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
by: E N Shu, et al.
Published: (2004-01-01)

Importance of ivermectin to human onchocerciasis: past, present, and the future
by: Cupp EW, et al.
Published: (2011-05-01)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021-03-01)

Ivermectin therapy for onchocerciasis: Effect on some haematological and biochemical parameters
by: E N Shu, et al.
Published: (2008-01-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
by: Olaitan Olamide Omitola, et al.
Published: (2021-04-01)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017-08-01)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
by: Elhassan Elizabeth, et al.
Published: (2011-07-01)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
by: Mounkaila Noma, et al.
Published: (2014-07-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
by: Proaño Roberto, et al.
Published: (2007-05-01)

Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
by: Luc E Coffeng, et al.
Published: (2014-01-01)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014-05-01)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
by: Wondafrash Mekite, et al.
Published: (2010-06-01)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018-04-01)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
by: Mary Amuyunzu-Nyamongo, et al.
Published: (2011-05-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
by: Tekle Afework, et al.
Published: (2012-02-01)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
by: Wilma A. Stolk, et al.
Published: (2015-10-01)

Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia
by: Adugna Endale, et al.
Published: (2015-02-01)

Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
by: Mike Y Osei-Atweneboana, et al.
Published: (2011-03-01)

Edaphic and climatic factors influence on the distribution of soil transmitted helminths in Kogi East, Nigeria
by: Clement Ameh Yaro, et al.
Published: (2021-04-01)

Adverse reactions from community directed treatment with ivermectin (CDTI ) for onchocerciasis and loiasis in Ondo State, Nigeria
by: O.A Otubanjo, et al.
Published: (2008-12-01)

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin
by: Uwem F. Ekpo, et al.
Published: (2022-11-01)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017-01-01)

Prevalence of onchocerciasis and epilepsy in a Tanzanian region after a prolonged community-directed treatment with ivermectin
by: Mushi, VP, et al.
Published: (2024)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2018-06-01)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023-08-01)

Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia.
by: Gebremedhin Gebrezgabiher, et al.
Published: (2022-01-01)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015-11-01)

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2019-05-01)

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014-02-01)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009-07-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
by: Charlotte Boullé, et al.
Published: (2019-03-01)

Comparison of some immunological parameters between untreated and ivermectin-treated onchocerciasis patients in the Nkwanta North District of Ghana
by: J. Labadah, et al.
Published: (2020-12-01)